Ishikawa Toru, Imai Michitaka, Ko Masayoshi, Sato Hiroki, Nozawa Yujiro, Sano Tomoe, Iwanaga Akito, Seki Keiichi, Honma Terasu, Yoshida Toshiaki
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata 950-1104, Japan.
Biomed Rep. 2017 Jan;6(1):99-102. doi: 10.3892/br.2016.811. Epub 2016 Nov 16.
Percutaneous transhepatic obliteration (PTO) and percutaneous transhepatic sclerotherapy (PTS) are widely performed as an emergency measure in cases of variceal hemorrhage and intractable hepatic encephalopathy. The PTO/PTS technique is capable of directly blocking the blood supply in cases in which balloon-occluded retrograde transvenous obliteration (B-RTO) is not effective, or in cases with complicated collateral flow. Although PTO/PTS is not currently the first choice due to the invasiveness of transhepatic puncture, this procedure can modify the blood flow in an antegrade manner. The present study examined the changes in hepatic function reserve following PTO/PTS for intractable hepatic encephalopathy and/or gastric varices. In total, the study included 37 patients (mean age, 61.75±12.77 years; age range, 32-88 years; male to female ratio, 23:14) with a variety of gastrorenal shunts, or B-RTO-intractable hepatic encephalopathy and gastric varices without gastrorenal shunts. The patients underwent PTO/PTS by embolizing a microcoil or injection of a sclerosing agent (5% ethanolamine oleate iopamidol). Alterations in hepatic function reserve prior to and following the procedure were compared. The patients were treated for hepatic encephalopathy in 11 patients, gastric varices in 19 patients, and both conditions in 7 patients. The results indicated that the blood ammonia level improved from 135.76±75.23 mg/dl to 88.00±42.16 and 61.81±33.75 mg/dl at 3 and 6 months after therapy, respectively. In addition, the Child-Pugh score improved from 8.48±2.01 prior to therapy to 7.70±1.84 and 7.22±2.01 at 3 and 6 months after the procedure, respectively. Although there was a concern that PTO/PTS may cause complications due to an increase in portal venous pressure (PVP) arising from shunt occlusion, no severe complications were observed. In conclusion, for patients with various gastrorenal shunts or those with B-RTO-intractable hepatic encephalopathy and gastric varices without gastrorenal shunts, PTO/PTS can improve the antegrade blood flow to the liver, as demonstrated by improvement in the hepatic function reserve.
经皮肝穿闭塞术(PTO)和经皮肝穿刺硬化疗法(PTS)作为静脉曲张出血和难治性肝性脑病病例的紧急措施被广泛应用。在球囊闭塞逆行静脉闭塞术(B-RTO)无效或存在复杂侧支血流的情况下,PTO/PTS技术能够直接阻断血液供应。尽管由于经肝穿刺的侵入性,PTO/PTS目前并非首选,但该手术可以顺行性改变血流。本研究探讨了PTO/PTS治疗难治性肝性脑病和/或胃静脉曲张后肝功能储备的变化。该研究共纳入了37例患者(平均年龄61.75±12.77岁;年龄范围32 - 88岁;男女比例23:14),这些患者存在各种胃肾分流,或B-RTO难治性肝性脑病和无胃肾分流的胃静脉曲张。患者接受了通过栓塞微线圈或注射硬化剂(5%油酸乙醇胺碘帕醇)进行的PTO/PTS治疗。比较了手术前后肝功能储备的变化。11例患者接受了肝性脑病治疗,19例患者接受了胃静脉曲张治疗,7例患者同时接受了两种疾病的治疗。结果表明,治疗后3个月和6个月时,血氨水平分别从135.76±75.23mg/dl改善至88.00±42.16mg/dl和61.81±33.75mg/dl。此外,Child-Pugh评分分别从治疗前的8.48±2.01改善至术后3个月的7.70±1.84和6个月的7.22±2.01。尽管有人担心PTO/PTS可能因分流闭塞导致门静脉压力(PVP)升高而引起并发症,但未观察到严重并发症。总之,对于存在各种胃肾分流的患者或患有B-RTO难治性肝性脑病和无胃肾分流的胃静脉曲张患者,PTO/PTS可改善肝脏的顺行血流,肝功能储备的改善证明了这一点。